Inhibikase Therapeutics, Inc. SEC filings IKT
Inhibikase Therapeutics, Inc. has 368 filings in SEC EDGAR's recent list, going back to Aug 31, 2018. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 20, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Oct 21, 2026 | Oct 19, 2026 |
| 3 | Initial insider ownership | Oct 21, 2026 | Oct 19, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 20, 2026 | Oct 19, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 8, 2026 | Sep 8, 2026 |
| 8-K |
Current report
Auditor change
|
Aug 26, 2026 | Aug 21, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2026 | — |
| S-8 | Employee stock plan registration | Aug 11, 2026 | — |
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2026 | Aug 11, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 31, 2026 | — |
| 4 | Insider transaction | Jul 31, 2026 | Jul 29, 2026 |
| 4 | Insider transaction | Jul 31, 2026 | Jul 30, 2026 |
| 8-K |
Current report
Unregistered share sale
|
Jul 29, 2026 | Jul 29, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 28, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 23, 2026 | Jul 23, 2026 |
| 3 | Initial insider ownership | Jul 17, 2026 | Jul 10, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 17, 2026 | — |
| 8-K |
Current report
Other events
|
Jul 14, 2026 | Jul 14, 2026 |
| 4 | Insider transaction | Jun 30, 2026 | Jun 26, 2026 |
| 4 | Insider transaction | Jun 30, 2026 | Jun 26, 2026 |
| 4 | Insider transaction | Jun 30, 2026 | Jun 26, 2026 |
| 4 | Insider transaction | Jun 30, 2026 | Jun 26, 2026 |
| 4 | Insider transaction | Jun 30, 2026 | Jun 26, 2026 |
| 4 | Insider transaction | Jun 30, 2026 | Jun 26, 2026 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jun 29, 2026 | Jun 26, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| ARS | Annual report to shareholders | Apr 30, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| DEF 14A | Proxy statement | Apr 30, 2026 | Jun 26, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 20, 2026 | Jun 26, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 7, 2026 | Apr 7, 2026 |
| S-8 | Employee stock plan registration | Mar 26, 2026 | — |
| 10-K | Annual report | Mar 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 26, 2026 | Mar 26, 2026 |
| 4 | Insider transaction | Feb 24, 2026 | Feb 21, 2026 |
| 4 | Insider transaction | Feb 24, 2026 | Feb 21, 2026 |
| 4 | Insider transaction | Feb 24, 2026 | Feb 21, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| 4 | Insider transaction | Jan 7, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 7, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 7, 2026 | Jan 5, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 31, 2025 | — |
| 8-K |
Current report
Other events
|
Dec 19, 2025 | Dec 19, 2025 |
| 424B5 | Prospectus supplement | Dec 19, 2025 | — |
| 4 | Insider transaction | Nov 24, 2025 | Nov 21, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Nov 21, 2025 | Nov 20, 2025 |
| 424B5 | Prospectus supplement | Nov 21, 2025 | — |
| 424B5 | Prospectus supplement | Nov 20, 2025 | — |
| 8-K |
Current report
Other events
|
Nov 20, 2025 | Nov 20, 2025 |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2025 | Nov 14, 2025 |
| 3/A | Filing | Aug 28, 2025 | Feb 21, 2025 |
| 3/A | Filing | Aug 28, 2025 | Feb 21, 2025 |
| 4 | Insider transaction | Aug 28, 2025 | Feb 21, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 14, 2025 | Aug 14, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2025 | — |
| 3/A | Primary document | Jul 15, 2025 | Jun 6, 2025 |
| 4/A | Filing | Jul 2, 2025 | Feb 21, 2025 |
| 4/A | Filing | Jul 2, 2025 | Feb 21, 2025 |
| 4/A | Filing | Jul 2, 2025 | Feb 21, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 30, 2025 | Jun 27, 2025 |
| EFFECT | Filing | Jun 27, 2025 | — |
| CORRESP | Letter to the SEC | Jun 25, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 25, 2025 | — |
| S-3 | Shelf registration | Jun 20, 2025 | — |
| DEFA14A | Additional proxy material | Jun 12, 2025 | — |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 14, 2025 | May 14, 2025 |
| ARS | Annual report to shareholders | May 12, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | May 12, 2025 | — |
| DEF 14A | Proxy statement | May 12, 2025 | Jun 27, 2025 |
| PRE 14A | Preliminary proxy statement | May 2, 2025 | Jun 27, 2025 |
| 10-K/A | Amended annual report | Apr 25, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Apr 16, 2025 | Apr 14, 2025 |
| 3 | Initial insider ownership | Apr 16, 2025 | Apr 14, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 14, 2025 | Apr 11, 2025 |
| S-8 | Employee stock plan registration | Mar 27, 2025 | — |
| 10-K | Annual report | Mar 27, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 27, 2025 | Mar 27, 2025 |
| 4 | Insider transaction | Feb 25, 2025 | Feb 21, 2025 |
| 4 | Insider transaction | Feb 25, 2025 | Feb 21, 2025 |
| 4 | Insider transaction | Feb 25, 2025 | Feb 21, 2025 |
| 3 | Initial insider ownership | Feb 25, 2025 | Feb 21, 2025 |
| 3 | Initial insider ownership | Feb 25, 2025 | Feb 21, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Regulation FD disclosure
|
Feb 24, 2025 | Feb 21, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 14, 2025 |
| 3 | Initial insider ownership | Feb 19, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 14, 2025 |
| 4/A | Filing | Feb 19, 2025 | Jan 21, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 14, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Feb 18, 2025 | Feb 13, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| S-8 | Employee stock plan registration | Feb 4, 2025 | — |
| 8-K |
Current report
Other events
|
Jan 29, 2025 | Jan 29, 2025 |
| 4 | Insider transaction | Jan 22, 2025 | Jan 21, 2025 |
| 4 | Insider transaction | Jan 22, 2025 | Jan 21, 2025 |
| 4 | Insider transaction | Jan 22, 2025 | Jan 21, 2025 |
| 4 | Insider transaction | Jan 22, 2025 | Jan 21, 2025 |
| EFFECT | Filing | Jan 16, 2025 | — |
| CORRESP | Letter to the SEC | Jan 14, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 14, 2025 | — |
| S-3 | Shelf registration | Jan 10, 2025 | — |
| 4 | Insider transaction | Jan 7, 2025 | Jan 3, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 3, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 3, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 3, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jan 6, 2025 | Jan 3, 2025 |
| EFFECT | Filing | Dec 5, 2024 | — |
| 8-K |
Current report
Agreement ended
|
Dec 5, 2024 | Dec 2, 2024 |
| 424B3 | Prospectus | Dec 5, 2024 | — |
| CORRESP | Letter to the SEC | Dec 3, 2024 | — |
| S-3/A | Filing | Dec 3, 2024 | — |
| S-3 | Shelf registration | Nov 18, 2024 | — |
| DEF 14A | Proxy statement | Nov 18, 2024 | Jan 3, 2025 |
| SC 13G | Ownership over 5% (passive) | Nov 14, 2024 | — |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| PRE 14A | Preliminary proxy statement | Nov 8, 2024 | Jan 3, 2025 |
| SC 13G | Ownership over 5% (passive) | Oct 28, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Oct 28, 2024 | — |
| 3 | Initial insider ownership | Oct 25, 2024 | Oct 21, 2024 |
| SC 13G | Ownership over 5% (passive) | Oct 25, 2024 | — |
| 4 | Insider transaction | Oct 23, 2024 | Oct 21, 2024 |
| 4 | Insider transaction | Oct 23, 2024 | Oct 21, 2024 |
| 4 | Insider transaction | Oct 23, 2024 | Oct 21, 2024 |
| 4 | Insider transaction | Oct 23, 2024 | Oct 21, 2024 |
| 3 | Initial insider ownership | Oct 23, 2024 | Oct 21, 2024 |
| 3 | Initial insider ownership | Oct 23, 2024 | Oct 21, 2024 |
| 3 | Initial insider ownership | Oct 23, 2024 | Oct 21, 2024 |
| 3 | Initial insider ownership | Oct 23, 2024 | Oct 21, 2024 |
| SC 13G | Ownership over 5% (passive) | Oct 22, 2024 | — |
| 8-K |
Current report
Material agreement, Officer or director change, Regulation FD disclosure
|
Oct 22, 2024 | Oct 21, 2024 |
| SC 13G | Ownership over 5% (passive) | Oct 17, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Oct 17, 2024 | — |
| SC 14F1 | Filing | Oct 11, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Regulation FD disclosure, Other events
|
Oct 10, 2024 | Oct 9, 2024 |
| SC 13G | Ownership over 5% (passive) | Oct 10, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 9, 2024 | Oct 9, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Aug 6, 2024 | Aug 5, 2024 |
| 4 | Insider transaction | Jul 18, 2024 | Jul 16, 2024 |
| 4 | Insider transaction | Jul 18, 2024 | Jul 16, 2024 |
| 4 | Insider transaction | Jul 18, 2024 | Jul 16, 2024 |
| 4 | Insider transaction | Jul 18, 2024 | Jul 16, 2024 |
| 424B3 | Prospectus | Jun 27, 2024 | — |
| EFFECT | Filing | Jun 26, 2024 | — |
| CORRESP | Letter to the SEC | Jun 24, 2024 | — |
| DEFA14A | Additional proxy material | Jun 21, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 21, 2024 | — |
| DEF 14A | Proxy statement | Jun 20, 2024 | Aug 5, 2024 |
| S-1 | Registration statement | Jun 18, 2024 | — |
| PRE 14A | Preliminary proxy statement | Jun 10, 2024 | Aug 5, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2024 | Jun 7, 2024 |
| D | Filing | Jun 4, 2024 | — |
| 424B5 | Prospectus supplement | May 22, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
May 20, 2024 | May 20, 2024 |
| 424B5 | Prospectus supplement | May 20, 2024 | — |
| 10-Q | Quarterly report | May 15, 2024 | Mar 31, 2024 |
| RW | Filing | May 15, 2024 | — |
| S-1/A | Amended registration statement | May 9, 2024 | — |
| S-1/A | Amended registration statement | May 9, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 30, 2024 | Apr 26, 2024 |
| S-1/A | Amended registration statement | Apr 29, 2024 | — |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 7, 2024 |
| S-1/A | Amended registration statement | Apr 25, 2024 | — |
| S-1 | Registration statement | Apr 19, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 19, 2024 | Apr 18, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 15, 2024 | Jun 7, 2024 |
| 4 | Insider transaction | Apr 3, 2024 | Apr 1, 2024 |
| 4 | Insider transaction | Apr 2, 2024 | Apr 1, 2024 |
| 3 | Initial insider ownership | Apr 2, 2024 | Apr 1, 2024 |
| 8-K/A |
Amended current report
Officer or director change
|
Apr 2, 2024 | Jan 16, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- IKT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Wilmington, DE
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1750149
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.